The analgesic effect of apelin-13 and its mechanism of action within the nitric oxide and serotonin pathways.
BACKGROUND
Apelin has various effects on a lot of systems such as central nervous system and cardiovascular system. This study investigated the possible analgesic effects of apelin-13 using the hot-plate and the tail-flick thermal analgesia tests in rats. We also evaluated the mechanism underlying the analgesic effects of apelin-13 by pretreating with Nw-nitro-L-arginine methyl ester (L-NAME) or ondansetron.


METHODS
Forty male rats were used. The rats were randomly assigned to five groups according to the treatment received: Group I: Control; Group II: Morphine; Group III: Apelin-13; Group IV: Apelin-13+L-NAME; Group V: Apelin-13+Ondansetron. Acute thermal pain was modeled using the hot-plate and the tail-flick tests.


RESULTS
During the hot-plate test, i.p. Morphine and apelin-13 administered at zero- and 30 min produced significantly greater analgesic effects compared to the control. When the nitric oxide pathway was inhibited by administration of L-NAME with apelin-13, the analgesic effect continued. When apelin-13 and ondansetron were co-administered, the analgesic effect of apelin-13 disappeared at zero- and 30 min. During the tail-flick test, at 30 min, significantly higher levels of analgesia were observed in both the morphine and apelin group (which did not differ from each other) compared to the control group. L-NAME co-administered with apelin-13 did not affect the degree of analgesia, but apelin-13 co-administered with ondansetron was associated with a greater reduction in analgesia compared to the other groups.


CONCLUSIONS
Our results demonstrate that apelin-13 exerts an analgesic effect; co-administration of apelin-13 and ondansetron inhibits antinociception, an effect apparently mediated by five-hydroxytryptamine-three (5-HT3) receptors. Hippokratia 2015; 19 (4): 319-323.
Department of Emergency Medicine, Medical Faculty, University of Inonu, Malatya, Turkey.
M G
MG
Turtay
Family health center, Demirkoy, Kırklareli, Turkey.
M
M
Karabas
Department of Pharmacology, Medical Faculty, University of Inonu, Malatya, Turkey.
H
H
Parlakpinar
Department of Biostatistics and Medical Informatics , Medical Faculty, University of Inonu, Malatya, Turkey.
C
C
Colak
Department of Pharmacology, Medical Faculty, University of Gaziosmanpasa, Tokat, Turkey.
M
M
Sagir
Apelin-13; analgesic; nitric oxide; rat; serotonin
Anesth Analg. 2002 Jun;94(6):1553-7, table of contents
12032025
Neuroendocrinology. 2000 Dec;72(6):400-7
11146423
Neuroreport. 1998 Feb 16;9(3):367-72
9512373
Biochem Biophys Res Commun. 1998 Oct 20;251(2):471-6
9792798
J Biol Chem. 2006 Jul 7;281(27):18317-26
16679320
Life Sci. 1999;64(15):1313-9
10227587
J Hypertens. 2011 Mar;29(3):415-24
21150639
Circ Res. 2002 Sep 6;91(5):434-40
12215493
Brain Res Bull. 2013 Aug;97:53-62
23751198
Physiol Genomics. 2006 Mar 13;25(1):153-65
16403840
Rapid Commun Mass Spectrom. 2010 Oct 15;24(19):2875-84
20857448
Mech Dev. 2002 Jan;110(1-2):183-6
11744380
Regul Pept. 2005 Nov;131(1-3):12-7
15970338
J Pharmacol Methods. 1989 Mar;21(1):21-31
2704245
Regul Pept. 2001 Jun 15;99(2-3):87-92
11384769
J Recept Signal Transduct Res. 2016;36(3):243-7
26460872
Eksp Klin Farmakol. 2014;77(6):33-8
25102734
J Neurochem. 2000 Jan;74(1):34-41
10617103
Curr Ther Res Clin Exp. 2013 Dec;75:22-6
24465038
Neuropharmacology. 2013 Dec;75:445-57
24035921
Protein Pept Lett. 2013 Aug;20(8):926-31
23360367
Peptides. 2007 Oct;28(10):2023-9
17719140
Neuroscience. 2012 Feb 17;203:207-15
22209919
Peptides. 2009 Jun;30(6):1153-7
19463749
J Pharmacol Exp Ther. 1953 Mar;107(3):385-93
13035677
Burns. 2014 Jun;40(4):759-71
24290856
Pharmacol Rep. 2012;64(5):1155-65
23238472